Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIα

被引:28
作者
Baker, RK
Kurz, EU
Pyatt, DW
Irons, RD
Kroll, DJ
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Prevent Med,Canc Ctr, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pathol, Denver, CO 80262 USA
关键词
D O I
10.1182/blood.V98.3.830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic exposure to benzene is associated with hematotoxicity and acute myelogenous leukemia. Inhibition of topoisomerase II alpha (topo 11) has been implicated in the development of benzene-induced cytogenetic aberrations. The purpose of this study was to determine the mechanism of topo 11 inhibition by benzene metabolites. In a DNA cleavage/relaxation assay, topo 11 was inhibited by p-benzoquinone and hydroquinone at 10 muM and 10 muM, respectively. On peroxidase activation, Inhibition was seen with 4,4'-biphenol, hydroquinone, and catechol at 10 muM, 10 muM, and 30 muM, respectively. But, In no case was cleavable complex stabilization observed and the metabolites appeared to act at an earlier step of the enzyme cycle. In support of this conclusion, several metabolites antagonized etoposide-stabilized cleavable complex formation and Inhibited topo R-DNA binding. It is therefore unlikely that benzene-induced acute myelogenous leukemia stems from events Invoked for leukemogenic topo 11 cleavable complex-stabilizing antitumor agents. (C) 2001 by The American Society of Hematology.
引用
收藏
页码:830 / 833
页数:4
相关论文
共 27 条
[1]  
BAKER RK, 2000, TOXICOLOGIST, V54, P1655
[2]   ETOPOSIDE (VP-16-213)-INDUCED GENE ALTERATIONS - POTENTIAL CONTRIBUTION TO CELL-DEATH [J].
BERGER, NA ;
CHATTERJEE, S ;
SCHMOTZER, JA ;
HELMS, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8740-8743
[3]   TOPOISOMERASE INHIBITION BY PHENOLIC METABOLITES - A POTENTIAL MECHANISM FOR BENZENES CLASTOGENIC EFFECTS [J].
CHEN, HW ;
EASTMOND, DA .
CARCINOGENESIS, 1995, 16 (10) :2301-2307
[4]  
EASTMOND DA, 1986, MOL PHARMACOL, V30, P674
[5]   AN INTERACTION OF BENZENE METABOLITES REPRODUCES THE MYELOTOXICITY OBSERVED WITH BENZENE EXPOSURE [J].
EASTMOND, DA ;
SMITH, MT ;
IRONS, RD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 91 (01) :85-95
[6]   Secondary leukemias induced by topoisomerase-targeted drugs [J].
Felix, CA .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :233-255
[7]   The ortho-quinone metabolite of the anticancer drug etoposide (VP-16) is a potent inhibitor of the topoisomerase II DNA cleavable complex [J].
Gantchev, TG ;
Hunting, DJ .
MOLECULAR PHARMACOLOGY, 1998, 53 (03) :422-428
[8]  
GOLDSTEIN BD, 2000, J TOXICOL ENV HLTH S, V2, P69
[9]  
IRONS RD, 1981, J RETICULOENDOTH SOC, V30, P359
[10]   EFFECTS OF THE PRINCIPAL HYDROXY-METABOLITES OF BENZENE ON MICROTUBULE POLYMERIZATION [J].
IRONS, RD ;
NEPTUN, DA .
ARCHIVES OF TOXICOLOGY, 1980, 45 (04) :297-305